首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Amide derivatives of 9,11-seco-estra-1,3,5(10)-trien-11-oic acid as modified orally active estrogen agonists with moderate antagonistic activity.
【24h】

Amide derivatives of 9,11-seco-estra-1,3,5(10)-trien-11-oic acid as modified orally active estrogen agonists with moderate antagonistic activity.

机译:9,11-seco-estra-1,3,5(10)-trien-11-oic acid的酰胺衍生物作为修饰的口服活性雌激素激动剂,具有中等拮抗活性。

获取原文
获取原文并翻译 | 示例
       

摘要

Synthesis of amide derivatives of 9,11-seco-estra-1,3,5(10)-trien-11-oic acid containing alkyl and aromatic amine residues has been carried out with an aim to prepare orally active estrogen antagonists. Modification of the estradiol molecule in the form of C-seco-amide derivatives has led to their high oral absorption. Compounds 7 an n-propyl amide, 8 an n-butyl amide, and 16 a p-anisidyl amide of C-seco-estrane showed significant estrogen antagonistic activity (>20%), while, the majority of compounds possessed high estrogen agonistic activity on oral administration at 10mg/kg dose in rats.
机译:为了制备具有口服活性的雌激素拮抗剂,已经合成了含有烷基和芳族胺残基的9,11-seco-estra-1,3,5(10)-三烯-11-油酸的酰胺衍生物。 C-半乳糖酰胺衍生物形式的雌二醇分子的修饰导致它们的高口服吸收。 C-seco-estrane的化合物7正丙基酰胺,8正丁基酰胺和16α对茴香基酰胺显示出显着的雌激素拮抗活性(> 20%),而大多数化合物具有很高的雌激素激动活性在大鼠中以10mg / kg的剂量口服。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号